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Abstract: Aspergillus fumigatus is a major fungal
pathogen that may be fatal to immunocompromised
individuals and causes airway hyperreactivity and re-
modeling in sensitized individuals. Herein, we exam-
ined the role of mannose-binding lectin (MBL), a
complement-activating plasma protein, during pul-
monary innate and allergic immune responses di-
rected against A. fumigatus spores or conidia. Nei-
ther group of nonsensitized MBL-A-sufficient (MBL-
A/) nor -deficient (MBL-A/) mice challenged
with an intravenous or intratracheal (i.t.) bolus of A.
fumigatus spores experienced fungus-induced mor-
tality, but marked airway remodeling was observed in
MBL-A/ mice challenged i.t. with conidia. In a
model of chronic fungal asthma, MBL-A/ and
MBL-A/ A. fumigatus-sensitized mice were exam-
ined at days 4 and 28 after an i.t. challenge with A.
fumigatus conidia. Airway hyperresponsiveness in
sensitized MBL-A/ mice was significantly de-
creased at both times after conidia challenge com-
pared with the sensitized MBL-A/ group. In the
sensitized MBL-A/ mice, whole lung T helper cell
type 2 cytokine levels were significantly decreased at
day 4 after conidia, and whole lung interferon- lev-
els were significantly increased at day 28 after
conidia when compared with controls. However, his-
tological evidence showed similar airway remodeling
at day 28 after conidia (i.e., subepithelial fibrosis and
goblet cell metaplasia) in the two groups of mice.
Thus, these findings show that MBL-A is not required
for mouse survival following exposure to A. fumigatus
conidia, and this murine collectin isoform contrib-
utes to the development and maintenance of airway
hyperresponsiveness but not chronic airway remod-
eling during chronic fungal asthma. J. Leukoc. Biol.
75: 805–814; 2004.
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INTRODUCTION
Mannose-binding lectin (MBL) is a pattern-recognition mole-
cule that recognizes distinct pathogen-associated molecular
patterns (PAMPs) comprised of repeating mannose based on
the surface of microorganisms, and when MBL binds to these
microorganisms, it initiates the activation of the complement
cascade [1, 2]. MBL is a member of a family of collagenous
lectins or collectins, which possesses many of the functional
characteristics of immunoglobulin (Ig)M, IgG, and Clq, such as
an ability to trigger the activation of proserine protease com-
plexes that cleave C4 and C2 of the classical complement
pathway [3]. This response is a critical component of innate
immunity against a number of clinically relevant pathogens
including Aspergillus fumigatus, Candida species, Staphylo-
coccus aureus, -hemolytic group A streptococci, Escherichia
coli, Klebsiella species, and Haemophilus influenzae type b [4].
In humans, serum levels of this collectin are quite variable,
such that an individual may exhibit low, intermediate, or high
levels, and variability in circulating MBL levels, aside from
some notable exceptions [5], has been shown to correlate with
susceptibility, resistance to infection [6, 7], and possibly other
diseases [8, 9]. In addition, individuals with structural muta-
tions of the MBL gene appear to have an increased incidence
of infections [3].
Whereas one form of MBL is found in humans, mice contain
two homologous isoforms, MBL-A and MBL-C [10, 11]. MBL-C
(which was originally identified as the liver form, although
recent evidence indicates that both isoforms are generated by
hepatocytes and are found in the circulation [12]) is found in
greater abundance in mouse serum than MBL-A; both are
typically found in microgram quantities, and the introduction
of lipopolysaccharide into mice induces MBL-A but not
MBL-C [13]. The recent generation of MBL-A null mice that
were MBL-C-sufficient has facilitated the examination of the
role of MBL-A in innate immune responses to bacteria and
fungus. One study led to the interesting observation that mu-
rine MBL-A is involved in the regulation of cytokine generation
during bacterial-induced septic peritonitis [14]. As a result of
the ability of MBL-A to modulate the inflammatory response,
MBL-A-deficient (MBL-A/) mice showed an enhanced sur-
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vival response in this model of sepsis [14]. Thus, MBL is a
physiological, significant molecule in the innate immune re-
sponse.
The spores or conidia of A. fumigatus are a constant airborne
challenge to humans and animals alike, particularly in devel-
oped countries [15]. This ubiquitous airborne saprophytic fungi
is normally contained and eliminated by neutrophil and mac-
rophage-driven innate immune events in the immunocompetent
host by innate immune mechanisms [16]. A. fumigatus is major
clinical concern in immunocompromised patients, as this fun-
gus can grow to the point of fatal invasive aspergillosis. Non-
immunocompromised individuals can also be adversely af-
fected by pulmonary exposure to this fungus, as those sensi-
tized to this fungus are at risk for allergic bronchopulmonary
aspergillosis, fungal asthma, or chronic necrotizing pulmonary
aspergillosis (CNPA) [15]. Recently, it was shown that indi-
viduals deficient in MBL were susceptible to CNPA [17], but
aside from this study, little in known about the in vivo role of
MBL in the immune response to A. fumigatus.
Thus, in the present study, we investigated the role of
MBL-A in pulmonary innate and allergic responses to A.
fumigatus in MBL-A-sufficient (MBL-A/) and MBL-A/
mice. Specific pathogen-free (SPF) MBL-A/ mice did not
succumb to an intravenous (i.v.) or intratracheal (i.t.) bolus
challenge with live A. fumigatus conidia. In a well-established
model of chronic fungal asthma [18], MBL-A/ mice, in
contrast with their wild-type counterparts, exhibited airway
remodeling following the i.t. challenge of conidia. The allergic
airway response to A. fumigatus conidia also differed between
MBL-A/ and MBL-A/ mice; airway hyperreactivity,
but not airway remodeling, was attenuated in the deficient mice
compared with their wild-type counterparts during the course
of chronic fungal asthma.
MATERIALS AND METHODS
MBL-A–/– mice
The generation of the MBL-A–/– mice used in the following experiments has
been described in detail previously [14]. Briefly, mice were generated using the
129SvJ MBL-A on a C57Bl/6J background. Embryonic stem clones were
injected into C57Bl/6J blastocysts. The resulting chimeras were crossed to
C57Bl/6J mice, genotyped by Southern, and crossed five times to discern the
stability of the genotype, and the colony was expanded. All MBL-A/ mice
were shown to be completely deficient in MBL-A but sufficient in the other
form of MBL found in mice, MBL-C [14]. The disruption of the MBL-A gene
did not influence the genetic expression of surfactant protein A, a collectin
with known regulatory functions in the lung that has a close genetic link to
MBL-A on chromosome 14 (data not shown). MBL-A/ and similarly
derived MBL-A/ mice were bred in a SPF facility at the University of
Michigan Medical School (Ann Arbor).
A. fumigatus culture and conidia challenge of
nonsensitized MBL-A/ and MBL-A/ mice
A. fumigatus American Type Culture Collection (Manassas, VA) strain 13073
was used in the present studies and was grown according to our previously
published protocol [18, 19]. Conidia were extensively washed to remove all
debris such as mycelium before quantification and injection into MBL-A/
and MBL-A/ mice. In the present study, groups of five MBL-A/ mice
were challenged i.t. with 5.0  106 conidia suspended in 30 l 0.1%
Tween-80 in phosphate-buffered saline (PBS). Groups of five MBL-A/
mice received 1.0  106 or 5.0  106 conidia via the i.t. route. In separate
experiments, MBL-A/ mice (n5) received 5.0  105 conidia suspended
in 500 l 0.1% Tween-80 in PBS. MBL-A/ mice also received conidia via
the i.v. route; 5.0  105 or 1.0  105 conidia was administered to groups of
five MBL-A/ mice. Each experimental treatment was conducted once.
Mouse survival was monitored in all groups of challenged mice. At day 28 after
conidia challenge, whole lung tissue was removed from each surviving mouse
to assess histological changes (see below).
Sensitization of MBL-A/ and MBL-A/ mice
to A. fumigatus and establishment of chronic
fungal asthma
Age-matched, SPF male and female MBL-A/ and MBL-A/ mice were
maintained in a SPF facility for the duration of this study. Prior approval for
mouse use in the development of this allergic fungal asthma model was
obtained from the University Laboratory Animal Medicine facility at the
University of Michigan Medical School. Sensitization of mice to a commercially
available preparation of soluble A. fumigatus antigens (Greer Laboratories,
Lenoir, NC) was performed as described previously [18]. Briefly, mice received
a total of 10 g A. fumigatus antigens dissolved in 0.2 ml incomplete Freund’s
adjuvant (Sigma Chemical Co., St. Louis, MO), distributed equally between an
intraperitoneal (i.p.) and a subcutaneous injection. Two weeks later, and for 3
subsequent weeks, mice received a total of 20 g A. fumigatus antigen,
dissolved in normal saline, by intranasal (i.n.) installation. One week after the
third i.n. challenge, each mouse received 5.0  106 live A. fumigatus conidia
suspended in 30 l 0.1% Tween-80 via the i.t. route.
Measurement of bronchial hyperresponsiveness
At days 4 and 28 after the i.t. A. fumigatus conidia challenge, bronchial
hyperresponsiveness in A. fumigatus-sensitized MBL-A/ and MBL-A/
mice was assessed in a BuxcoTM plethysmograph (Buxco, Troy, NY) [18]. Mice
were anesthetized with sodium pentobarbital (40 mg/ml i.p.; Butler Co.,
Columbus, OH) before their intubation and ventilation with a Harvard pump
ventilator (Harvard Apparatus, Reno, NV). Airway resistance was calculated
online via computer software (Buxco) and was determined by the division of the
transpulmonary pressure by the change in inspiratory volume. Following a
baseline period in the Buxco plethysmograph, anesthetized and intubated mice
received a dose of 210 and 420 g/kg methacholine by tail vein injection, and
airway responsiveness to this nonselective bronchoconstrictor was again cal-
culated. At day 4 when acute inflammation and airway hyperresponsiveness
are most pronounced, the lower 210-g dose of methacholine was used for the
airway hyperresponsiveness calculation, and the 420-g dose was used at day
28. At the conclusion of the assessment of airway hyperresponsiveness, 500 l
blood was collected from each mouse and transferred to a microcentrifuge tube.
Sera were obtained after the sample was centrifuged at 15,000 g for 10 min. A
bronchoalveolar lavage (BAL) was performed with 1 ml normal saline, and fluid
was removed from cells by centrifugation. BAL cells were subsequently
cytospun onto coded microscope slides for differential analysis (see below).
Finally, whole lungs were dissected from each mouse and snap-frozen in liquid
N2 or prepared for histological analysis.
Morphometric analysis of leukocyte
accumulation in BAL samples
Neutrophils, macrophages, eosinophils, and lymphocytes were quantified in
BAL samples cytospun onto coded microscope slides using a cytospin (Shan-
don Scientific, Runcorn, UK). Identification of each cell type was facilitated by
differential staining with Wright-Giemsa differential stain and expressed as
average cells per high-powered field (1000).
Enzyme-linked immunosorbent assay (ELISA)
analysis
Murine interleukin (IL)-4, IL-5, IL-13, interferon- (IFN-), tumor necrosis
factor  (TNF-), IL-10, IL-12, CXC chemokine ligand (CXCL)2, CXCL3,
CXCL9, CCL3, CCL5, CCL11, and CCL22 protein levels were determined in
50 l whole lung homogenates, using a standardized sandwich ELISA tech-
nique described previously in detail [20]. Whole lungs were homogenized in 1
ml normal saline containing 1 mg protease inhibitor (Complete™, Boehringer
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Mannheim, Indianapolis, IN). Recombinant murine cytokines and chemokines
were used to generate the standard curves from which the concentrations
present in the samples were derived. The limit of ELISA detection for each
cytokine and chemokine was consistently below 50 pg/ml, and the ELISA was
screened to ensure the specificity of each antibody used.
Whole lung histological analysis
Whole lungs from nonsensitized MBL-A/ and MBL-A/ mice at day 28
after A. fumigatus conidia challenge and from A. fumigatus-sensitized MBL-
A/ and MBL-A/ mice at days 4 and 28 after conidia were fully inflated
by i.t. perfusion with 4% paraformaldehyde. Lungs were then dissected and
placed in fresh paraformaldehyde for 24 h. Routine histological techniques
were used to paraffin-embed this tissue, and 5-m sections of whole lung were
stained with hematoxylin and eosin (H/E), periodic acid Schiff (PAS), and
Gomori methanamine silver (GMS).
Statistical analysis
All results are expressed as mean 	 SEM. A Student’s t-test was used to
determine statistical significance between the MBL-A/ and MBL-A/
groups at various times after conidia challenge; P 
 0.05 was considered
statistically significant.
RESULTS
MBL-A/ mice did not succumb to a bolus of
i.t. or i.v. A. fumigatus conidia
Immunocompetent mice are extremely resistant to the devel-
opment of invasive aspergillosis as a result of the potent
antifungal properties of recruited neutrophils and monocytes as
well as resident alveolar macrophages (reviewed in ref. [15]).
Typically, some mutation and/or chemical alteration of the
innate immune response is necessary before Aspergillus can
grow in the lung environment, thereby causing invasive as-
pergillosis [16]. In the present study, we saw no evidence that
the bolus introduction of live A. fumigatus conidia, by the i.t.
or i.v. route, had a deleterious effect on the survival of MBL-
A/ mice, as all challenged mice survived for the duration
of this study. One hundred percent survival was also observed
in all MBL-A/ groups. Thus, MBL-A deficiency did not
affect mouse survival following a pulmonary or systemic bolus
of A. fumigatus conidia.
Nonsensitized MBL-A/ mice exhibited
peribronchial inflammation and goblet cell
metaplasia at day 28 after i.v. challenge with
A. fumigatus conidia
As the i.v. or i.t. administration of A. fumigatus conidia into
nonsensitized MBL-A/ mice did not adversely affect the
survival of these mice, we next examined whether the presence
of the conidia in these mice altered the histological appearance
of various tissues at day 28 after the conidia challenge. In
MBL-A/ and MBL-A/mice that received an i.v. bolus
of 1.0–5.0  105 A. fumigatus conidia, we observed no evi-
dence of tissue damage in kidney, lung, liver, and brain (not
shown) nor was there any histological evidence that A. fumiga-
tus was retained in any of the above tissues in MBL-A/
mice (i.e., GMS staining was absent), and this observation was
similar to that seen in MBL-A/ mice (GMS staining is not
shown for either group of mice). However, the i.t. challenge of
5.0  106 A. fumigatus conidia into MBL-A/ mice ap-
peared to cause major changes to the architecture of airways in
these mice. In contrast to MBL-A/ mice at day 28 after
conidia (Fig. 1, A and C), the lungs of MBL-A/ mice
exhibited marked peribronchial inflammation (Fig. 1B) and
goblet cell metaplasia (Fig. 1D). Thus, this histological analy-
sis revealed that the i.t. administration of A. fumigatus in
nonsensitized MBL-A/ mice promoted the maintenance of
airway inflammation and remodeling.
A. fumigatus-sensitized MBL-A/ mice
did not develop significant bronchial
hyperresponsiveness following A. fumigatus
conidia challenge
We next examined whether MBL-A deficiency altered the
course and/or magnitude of chronic fungal asthma. We have
extensively studied the allergic airway response invoked by the
introduction of A. fumigatus conidia into A. fumigatus-sensi-
tized mice, and airway hyperresponsiveness is a cardinal fea-
ture of this model [21]. Following i.t. challenge with live A.
fumigatus conidia, A. fumigatus-sensitized mice exhibit airway
hyperresponsiveness that is present several weeks after i.t.
challenge [18]. To assess the role of MBL-A in the initiation
and maintenance of airway hyperresponsiveness, i.v. injections
of 210 and 420 g/kg methacholine were administered to A.
fumigatus-sensitized MBL-A/ and MBL-A/ mice. Nei-
ther of these doses of methacholine caused a significant in-
crease in airway hyperresponsiveness above basal levels in A.
fumigatus-sensitized wild-type mice before the conidia chal-
lenge (data not shown). At day 4, the airway response was acute
in the MBL-A/ mice, and the lower 210-g/kg methacho-
line dose was required to show the magnitude of the difference
in airway responses between the two groups. At day 28, the
result from the 420-g/kg dose is reported. At days 4 (Fig. 2,
upper panel) and 28 (Fig. 2, lower panel) after conidia, metha-
Fig. 1. Representative photomicrographs of H/E (A and B)- and PAS (C and
D)-stained whole lung sections from nonsensitized MBL-A/ (A and C) and
MBL-A/ (B and D) mice at day 28 after conidia challenge. Both groups of
mice (nfive/group) were injected i.t. with 5.0  106 conidia. The peribron-
chial inflammatory response was markedly enhanced in the MBL-A/ group
(B) compared with the MBL-A/ (A) group. Although PAS-stained goblet
cells were absent in the MBL-A/ group (C), several goblet cells were
evident in the airways of MBL-A/ mice (D). Original magnification, 200.
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choline induced significant airway hyperresponsiveness in the
MBL-A/ group. In contrast, the A. fumigatus-sensitized
MBL-A/ mice exhibited significantly less airway hyperre-
sponsiveness when compared with the MBL-A/ controls
(Fig. 2, upper and lower panels). These data show that MBL-A
is necessary for the development of allergic airway hyperre-
sponsiveness in the context of A. fumigatus.
MBL-A deficiency significantly alters lymphocyte
recruitment into the airways of A. fumigatus-
sensitized mice after live conidia challenge
The accumulation of leukocytes in and around the airways is a
hallmark of allergic asthma. Therefore, leukocyte recruitment
into the lung was monitored at days 4 and 28 following conidia
challenge in A. fumigatus-sensitized MBL-A/ and MBL-
A/ mice (Fig. 3). The number of macrophages and neu-
trophils counted in the BALs from A. fumigatus-sensitized
MBL-A/ mice was significantly lower than that counted in
the BALs of similarly sensitized MBL-A/ mice at day 4
after conidia (Fig. 3, upper panel). In contrast, BAL eosinophil
counts were significantly higher in the knockout group com-
pared with the wild-type group at day 4 (Fig. 3, upper panel).
BAL lymphocyte counts did not differ between the two groups
of mice at this time point. At day 28 after conidia challenge
(Fig. 3, lower panel), eosinophil and lymphocyte numbers
within the BAL were significantly decreased in MBL-A/
mice compared with BAL samples from the MBL-A/
groups at both times after conidia (Fig. 3). Although these cells
were present in BAL samples from the MBL-A/ group, no
Fig. 3. Leukocyte counts in BAL samples from A. fumigatus-sensitized
MBL-A/ and MBL-A/ mice at days 4 and 28 after i.t. challenge with
5.0  106 A. fumigatus conidia. BAL cells were dispersed onto microscope
slides using a cytospin; neutrophils, eosinophils, lymphocytes, and macro-
phages were differentially stained with Wright-Giesma stain. A minimum of 20
high-powered fields was examined in each cytospin. Values are expressed as
mean 	 SEM of the total cells counted/high-powered field (1000).
Fig. 2. Airway resistance in A. fumigatus-sensitized MBL-A/ and MBL-
A/ mice at days 4 (upper) and 28 (lower) after i.t. challenge with 5.0  106
A. fumigatus conidia. Hyperresponsiveness, as measured by changes in airway
resistance (unitscm H2O/ml/s), was measured in MBL-A/ and MBL-
A/ mice at days 4 and 28 after conidia challenge. A baseline reading was
taken for each animal before methacholine injection (represented as solid lines
across methacholine-challenged response bars). At day 4, 210 g/kg metha-
choline was used to assess the airway response, and 420 g/kg methacholine
was used at day 28. Values are expressed as mean 	 SEM; n  five/group/time
point. *, P  0.05; **, P  0.01, compared with methacholine-induced airway
hyperresponsiveness in MBL-A/ mice.
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neutrophils were present in the BAL of the MBL-A/ group
at day 28. Taken together, these data suggested that the lack of
MBL-A significantly altered the recruitment of the major cell
types that have been implicated in Aspergillus-induced allergic
airway disease.
MBL-A/ mice exhibited a muted T helper cell
type 2 (Th2) cytokine response at day 4 after A.
fumigatus conidia challenge, followed by an
increase in IFN- at day 28
Numerous clinical [22, 23] and basic [24–27] studies have
shown that Th2 cytokines are present and participate in the
allergic inflammatory response elicited by A. fumigatus. There-
fore, we examined whether whole lung Th2 cytokine levels
were altered in MBL-A/ mice during the course of chronic
fungal asthma. As shown in Figure 4, whole lung levels of
IL-13 (Fig. 4A), IL-4 (Fig. 4B), and IL-5 (Fig. 4C) were
significantly lower in A. fumigatus-sensitized MBL-A/
mice compared with the wild-type group at day 4 after conidia.
At day 28 after conidia, no differences in whole lung Th2
cytokine levels were detected between the two groups of A.
fumigatus-sensitized mice; however, the level of the Th1 cyto-
kine IFN- was significantly higher in the knockout mice
compared with the wild-type controls (Fig. 4D). Although Th2
cytokines enhance allergic responses to Aspergillus, Th1 cyto-
kines, particularly IFN-, are potent inhibitors of this response
(reviewed in ref. [21]). Other cytokines relevant to immune
responses elicited by Aspergillus, including TNF- [28], IL-10
[29], and IL-12 [30], were not affected by MBL-A deficiency at
either time after conidia challenge in A. fumigatus-sensitized
mice (data not shown). These findings demonstrate that MBL-A
deficiency has a major effect on the early elaboration of Th2
cytokines in the lungs of A. fumigatus-sensitized mice during
chronic fungal asthma, and this may have implications in the
balance of Th1/Th2 cytokine production in the chronic stages
of the disease.
MBL-A deficiency modulated the whole lung
levels of CXCL9, CCL5, and CCL2 during the
course of chronic fungal asthma
In our previous studies, we have examined the role of various
chemokines in the initiation and maintenance of chronic fungal
asthma [21]. These data have shown that CC and CXC chemo-
kines have prominent but distinct roles in the physiologic,
Fig. 4. Whole lung cytokine levels in A. fumigatus-sensitized MBL-A/ and MBL-A/ mice at days 4 and 28 after i.t. challenge with 5.0  106 conidia.
Cell-free supernatants from whole lung samples by specific ELISA measured IL-13 (A), IL-4 (B), IL-5 (C), and IFN- (D). Specific cytokine levels were normalized
to total protein in each sample. Values are expressed as mean 	 SEM; n  five/group/time point. *, P  0.05; **, P  0.01; ***, P  0.001, compared with whole
lung cytokine levels in MBL-A/ mice.
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inflammatory, and remodeling responses in this model of
chronic fungal asthma. In the present study, ELISA measured
whole lung levels of the CXC chemokines relevant to chronic
fungal asthma including CXCL2, CXCL3, and CXCL9 [31].
Whole lung levels of CXCL2 and CXCL3 were not altered by
MBL-A deficiency, but the level of the Th1 cytokine-induced
CXCL9 was significantly lower in whole lung samples from the
MBL-A/ group at day 4 after conidia compared with the
MBL-A/ group at the same time (Fig. 5A). Major CC
chemokines relevant to this chronic fungal asthma model were
also measured, and they include CCL3 [32], CCL5 [33], CCL11
[34], and CCL22 [35]. Compared with the appropriate MBL-
A/ group, significantly higher levels of CCL5 (Fig. 5B) and
CCL22 (Fig. 5C) were detected in whole lung samples from the
MBL-A/ group at day 4 after conidia, and CCL5 remained
significantly higher in this group at day 28 after conidia.
Together, these data suggest that MBL-A negatively regulates
the elaboration of pro-allergic chemokines in the airways of
mice experiencing chronic fungal asthma.
Elimination of fungal material from the lungs of
A. fumigatus-sensitized mice was not impaired
by MBL-A deficiency
The presence of fungal material in tissues, such as the lung, is
readily identified using a GMS stain. In our previous studies of
this chronic fungal asthma model, we have observed that
certain gene-deficient mice are clearly impaired in their ability
to clear fungal material and conidia from their airways. One
example is the CCR2-deficient mouse, which shows persistent
evidence of GMS-positive fungal material in mononuclear cells
within and around major airways [36]. In the present study, we
observed some distinct differences in GMS staining in the
MBL-A/ and MBL-A/ groups (Fig. 6). In the wild-type
group, GMS-positive mononuclear cells were prominent at day
4 (Fig. 6A) after conidia challenge, whereas few GMS-positive
cells were present in the lungs of this group at day 28 (Fig. 6C).
In the MBL-A/ group, GMS-positive mononuclear cells
were present at day 4, but the majority of the GMS staining was
present in and around the pulmonary vasculature (Fig. 6B).
Although much less GMS staining was present in the lungs of
MBL-A/ mice at day 28, GMS staining was still prominent
in the vasculature. Thus, although the elimination of fungal
material from the airways did not appear to be impaired by
MBL-A deficiency, it was evident that the distribution of GMS
staining in the lungs of MBL-A differed from that observed in
the MBL-A/ mice.
Airway remodeling was not altered by MBL-A
deficiency during the course of chronic fungal
asthma
Further histological analysis of whole lung samples from MBL-
A/ and MBL/ mice revealed some differences between
these groups of mice during the course of fungal asthma. It was
apparent that the peribronchial inflammatory response was less
pronounced in the MBL-A/ group (Fig. 7A) at day 4 after
conidia compared with the MBL-A/ group (Fig. 7B). The
degree of peribronchial inflammation did not appear to differ
between the MBL-A/ (Fig. 7C) and the MBL-A/ (Fig.
Fig. 5. Whole lung chemokine levels in A. fumigatus-sensitized MBL-A/
and MBL-A/ mice at days 4 and 28 after i.t. challenge with 5.0  106 conidia.
Cell-free supernatants from whole lung samples by specific ELISA measured
CCL5, CCL22, and CXCL9. Specific levels were normalized to total protein in
each sample. Values are expressed as mean 	 SEM; n  five/group/time point. *,
P  0.05, compared with whole lung chemokine levels in MBL-A/ mice. MIG,
Monokine induced by IFN-; RANTES, regulated on activation, normal T ex-
pressed and secreted; MDC, macrophage-derived chemokine.
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7D) groups at day 28 after conidia. The MBL-A/ group
(Fig. 8B) had appreciably more goblet cell metaplasia at day
4 compared with the MBL-A/ group (Fig. 8A) at the same
time point after conidia, yet no difference could be detected
between the wild-type (Fig. 8C) and knockout (Fig. 8D) groups
at day 28 after conidia. Finally, the degree of peribronchial
fibrosis in the MBL-A/ (Fig. 9A) and the MBL-A/
(Fig. 9B) groups at day 28 was indistinguishable, which was
confirmed in a biochemical analysis of total collagen in whole
lung samples at this time (data not shown). Together, these data
suggested that certain airway remodeling features in this model
of chronic fungal asthma were accelerated by the absence of
MBL-A in A. fumigatus-sensitized mice, but at the latter time
point, the degree of airway remodeling was similar in both
groups of mice.
DISCUSSION
MBL is a liver-derived serum molecule that belongs to the
collectin family, a group of glycoproteins whose functions are
linked to innate immune responses against viral, fungal, mi-
crobial, and parasitic pathogens [2, 37]. The collectins have a
collagen-like domain and a C-type lectin domain. The human
collectins surfactant protein-A (SP-A), SP-D, and MBL-A are
found in a genetic cluster on chromosome 10 [38]. The genetic
grouping of these particular collectins is mirrored in the mu-
rine systems where they are clustered on chromosome 14 [39].
Recent research has revealed a protective role for SP-A and
SP-D in Aspergillus infection [40, 41]. The proximity of the
MBL-A gene to these important, functionally related, innate
molecules suggests a role for MBL-A in the immune response
to fungal pathogens.
Fig. 6. Representative photomicrographs of GMS-stained whole lung sections
from A. fumigatus-sensitized MBL-A/ (A and C) and MBL-A/ (B and
D) mice at days 4 (A and B) and 28 (C and D) after i.t. challenge with 5.0 
106 conidia. The arrows highlight fungal material. In MBL-A/ mice, the
majority of fungal material was observed in mononuclear cells at day 4 (A), and
little fungal material was observed at day 28 (C) after conidia challenge. In
MBL-A/ mice, the majority of fungal material was visualized around
pulmonary vessels. Original magnification, 200.
Fig. 7. Representative photomicrographs of H/E-stained whole lung sections
from A. fumigatus-sensitized MBL-A/ (A and C) and MBL-A/ (B and
D) mice at days 4 (A and B) and 28 (C and D) after i.t. challenge with 5.0 
106 conidia. MBL-A/ (B) mice exhibited markedly greater peribronchial
inflammation compared with the MBL-A/ (A) group at day 4 after conidia.
Original magnification, 200.
Fig. 8. Representative photomicrographs of PAS-stained whole lung sections
from A. fumigatus-sensitized MBL-A/ (A and C) and MBL-A/ (B and
D) mice at days 4 (A and B) and 28 (C and D) after i.t. challenge with 5.0 
106 conidia. MBL-A/ (B) mice exhibited markedly greater goblet cell
metaplasia compared with the MBL-A/ (A) group at day 4 after conidia.
Original magnification, 200.
Fig. 9. Representative photomicrographs of trichrome Masson-stained whole
lung sections from A. fumigatus-sensitized MBL-A/ (A) and MBL-A/
(B) mice at day 28 after i.t. challenge with 5.0  106 conidia. No differences
in peribronchial fibrosis were observed between the two groups. Original
magnification, 200.
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Through recognition of distinct PAMPs, MBL triggers com-
plement fixation through a modified classical pathway that
involves the activation of C4 and C2 via MBL-associated serine
proteases to generate complement components that have C3-
convertase activity (reviewed in ref. [1]). Considerable interest
in MBL has emerged because of growing clinical evidence that
MBL makes an important contribution to innate immunity, with
its absence typically increasing individual susceptibility to
infectious pathogens and/or affecting the course of underlying
disease [7, 9]. Although a strong association between MBL
deficiency and susceptibility to bacterial and parasitic infec-
tions has been documented [9], far less is known about the
importance of this collectin in antifungal responses. MBL
appears to be important in containing A. fumigatus, given a
recent clinical study that showed that decreased circulating
concentrations of MBL were significantly associated with the
presence of CNPA [17]. The advent of mice lacking one of the
two MBL isoforms found in mice [14, 42] allowed us to under-
take a detailed examination of the role of MBL in containing a
bolus challenge of A. fumigatus conidia in the context of
nonimmunocompromised mice that lacked prior sensitization
to A. fumigatus or mice that were systemically sensitized to
soluble A. fumigatus antigens.
The mode of recognition of Aspergillus conidia by phagocytes
has been studied previously and yielded the following: Prior
opsonization of the spores with normal rabbit serum, rabbit
anti-A. fumigatus serum, complement, or lung lavage fluid has
no profound enhancing effect on the phagocytosis or killing of
the spores [43]; optimal association between phagocyte and
conidia was dependent on an active, alternative complement
pathway [44]; conidia cell wall components can degrade bound
C3 [45, 46]; conidia pigmentation regulates C3 binding [47];
and bound MBL was able to promote C4 deposition in a
concentration-dependent manner [4]. Although MBL-A/
mice were not more susceptible to Candida albicans or Plas-
modium yoelil compared with MBL-A/ [42], we nonethe-
less first assessed whether MBL-A/ mice were similarly
resistant to an i.t. or i.v. challenge with live A. fumigatus
conidia. Our data, combined with the previous study in MBL-
A/ [42], suggest that the lack of MBL-A may not be
sufficient to profoundly impair the antifungal innate immune
response, given that MBL-C may fully compensate for the lack
of A isoform. However, MBL-A deficiency did have an effect on
the histological appearance of the lung, possibly suggesting
that the clearance of A. fumigatus from the lungs of nonsensi-
tized MBL-A/ mice was not as efficient as that in their
wild-type counterparts. The airway features most prominent in
the MBL-A/ group at day 28 after the i.t. introduction of
5.0  106 conidia were peribronchial inflammation and goblet
cell hyperplasia. Both of these airway features are cardinal
signs of persistence of fungal antigens with the lung, possibly
in a manner similar to that we have observed in the context of
A. fumigatus-sensitized mice [18]. One caveat to this hypoth-
esis is that we did not observe GMS-stained material in the
lungs of MBL-A/ mice, but it is possible that this histo-
logical technique for fungal antigen detection may not be
sufficiently sensitive to detect the minute amounts of fungal
antigen that may be driving the airway inflammatory and re-
modeling events. Thus, the lack of MBL-A did not affect
mortality following a bolus conidia challenge, but its absence
did affect the lung in a manner reminiscent of Aspergillus-
induced airway disease [21].
Asthma is a chronic, Th2, cytokine-dominated, inflammatory
disease of the lung, resulting in airway hyperreactivity and
remodeling. Th2 cytokines, particularly IL-4, IL-5, and IL-13,
regulate the airway hyperresponsiveness, eosinophil activation,
and mucus production. Although not historically viewed as
important in the pathogenesis of asthma [48], recent studies
have shown that the complement anaphylatoxins C3a [49–51]
and C5a [52] contribute to pulmonary allergy in experimental
allergic airway responses. The major features of allergic airway
disease that were significantly attenuated by the absence of
complement or complement receptors were airway hyperre-
sponsiveness, airway eosinophilia, and Th2 cytokine levels. In
the present study, the results obtained from A. fumigatus-
sensitized MBL-A/ mice, challenged i.t. with conidia,
shared similarities with those observed in the previous studies
referenced above [48]. At day 4 after conidia challenge in A.
fumigatus-sensitized MBL-A/ mice, we observed a pro-
found decrease in airway hyperreactivity and whole lung Th2
cytokine levels compared with their wild-type counterparts.
However, BAL eosinophilia was actually enhanced in the
day-4 MBL-A/ group. This finding is possibly explained by
the significant increases in potent eosinophil chemoattractants
CCL5 and CCL22 [33, 35] in the lungs of this group. Coincid-
ing with a significant increase in whole lung levels of IFN-,
airway hyperreactivity and BAL eosinophilia were significantly
attenuated at day 28 after conidia challenge in the MBL-A/
group compared with the MBL-A/ group. However, the
absence of MBL-A in A. fumigatus-sensitized mice did not
attenuate the goblet cell metaplasia and peribronchial fibrosis
typically associated with chronic fungal asthma [18]. This
finding contrasts with that of Drouin and colleagues [51] who
found that C3a receptor-deficient mice had significantly re-
duced mucus production compared with their wild-type con-
trols. Although we have observed a dissociation between air-
way responsiveness to methacholine challenge and airway re-
modeling (i.e., goblet cell metaplasia) during chronic fungal
asthma [32, 35, 53], it is possible that the presence of MBL-C
in MBL-A/ mice or inflammatory responses modulated by
chemokines such as CCL5 [33] and CCL22 [35] may have
promoted the airway remodeling features intensely evident at
day 28 after conidia challenge in both groups of sensitized
mice. Generation of mice deficient in both murine MBL iso-
forms may facilitate whether airway-remodeling events are
driven by MBL-C.
In summary, the present study demonstrates that MBL-A has
a nonredundant role in the context of murine innate and
allergic pulmonary responses to A. fumigatus conidia. Al-
though the mice examined in the present study were sufficient
in MBL-C [14], it was clear that the absence of MBL-A
modulated airway inflammatory and remodeling events in non-
sensitized and A. fumigatus-sensitized mice. Taken together,
these above findings recapitulate the earlier conclusions of
Takahashi et al. [14] in which they demonstrated that the role
of MBL-A appeared to extend beyond that of opsonin to mod-
ulator of inflammatory processes in the mouse.
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